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Influenza-associated hospitalisation
Key Message
The disease burden associated 
with influenza includes not only 
acute respiratory diseases but also 
cerebrovascular disease, ischaemic 
heart disease and diabetes mellitus.
Hong Kong Med J 2009;15(Suppl 9):S35-7
Introduction 
Influenza may result in hospitalisation, especially in young children and the 
elderly or in those with chronic diseases. Hospitalisation for influenza is 
under-reported owing to the non-specific symptoms of influenza and lack 
of laboratory tests. Excess hospitalisation and mortality associated with 
influenza have been used to measure the health impacts of influenza.1-3 Excess 
hospitalisation was calculated as the difference in hospitalisation numbers 
between the epidemic and non-epidemic periods within a year, or between 
the epidemic years with apparent influenza peaks and the baseline years 
without any apparent increase of influenza activity. It is difficult to apply 
the same approach to tropical and subtropical regions such as Hong Kong, 
where there are no well-defined epidemic periods or even clear seasonal 
patterns of influenza activity. We used Poisson regression to estimate the 
disease burden related to influenza in the circumstance without a clear 
influenza seasonality.4 
Aims and objectives
To evaluate influenza-associated hospitalisation for different age-groups in Hong 
Kong.
Methods 
The weekly numbers of hospital discharge diagnoses from 14 acute hospitals 
in Hong Kong during the period 1996-2000 were obtained from the Hospital 
Authority. The disease categories included acute respiratory disease (ARD) 
[International Classification of Diseases version 9 (ICD9) codes 460-466, 
480-487] and its sub-category pneumonia and influenza (P&I) [ICD9 480-
487], cerebrovascular disease (CVD) [ICD9 430-438], ischaemic heart 
disease (IHD) [ICD9 410-414] and diabetes mellitus [ICD9 250]. The weekly 
proportion of specimens positive for influenza A and B (influenza A+B), and 
for respiratory syncytial virus (RSV) were obtained from the microbiology 
laboratory of Queen Mary Hospital and were adopted to represent influenza 
and RSV activity. 
 We used Poisson regression to model the weekly counts of hospitalisation for 
each disease category.5 We built a core model to control for confounding factors 
including temperature, relative humidity, long-term trends and seasonality. This 
core model was accepted once the partial autocorrelation plots of its residuals 
did not have any discernible patterns. The variables influenza A+B and RSV 
were entered into the core model to assess the impacts of influenza activity with 
adjustment for RSV. The lag effects of influenza were assessed by entering the 
variable influenza A+B measured at 0-3 weeks before the admission week and 
selecting the one with the most significant effect (ie the smallest P value for the 
coefficient). 
 The percentage of excess hospitalisation attributable to influenza was 
calculated as the ratio of the difference between the total observed and expected 
hospitalisation under the assumption that influenza A+B was zero, to the total 
number of observed hospitalisation. This percentage of excess hospitalisation 
was then multiplied by the total hospitalisation per year to get the excess 
number, which was further divided by the population to obtain a rate of excess 
hospitalisation per 100 000 inhabitants.
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Results
In all age-groups, influenza was significantly associated 
with 10.9% of total hospitalisation for ARD, 11.6% 
for P&I, 1.5% for CVD, 1.8% for IHD and 3.5% for 
diabetes (P<0.01) [Table]. In addition, ARD and P&I were 
significantly associated with influenza (P<0.001). Influenza 
accounted for 9.3% and 11.5% of hospitalisation for ARD 
in the 0-14 and 65-74 years age-groups, respectively. For 
both disease categories, the influenza-associated excess 
hospitalisation rates per 100 000 inhabitants were estimated 
to be lowest (6.0 for ARD and 2.9 for P&I) in the 15-39 
years age-group, and highest (266.0 for ARD and 176.3 for 
P&I) in the 75+ years age-group (Table). 
 Influenza was significantly associated with 
hospitalisation for CVD (P=0.001) and IHD (P<0.01) only 
in the 75+ years age-group, with rates of 55.4 and 56.4 
per 100 000 inhabitants. Influenza was also significantly 
associated with 2.0% of all hospitalisation for IHD in the 
40-64 years age-group (P<0.05). In addition, influenza was 
significantly associated with hospitalisation for diabetes 
(P<0.01), with rates being 6.6, 23.9 and 53.3 per 100 000 
inhabitants in the 40-64, 65-74 and 75+ years age-groups, 
respectively. For all these chronic diseases CVD, IHD 
and diabetes, the rates of influenza-associated excess 
hospitalisation were highest in the 75+ years age-group 
(Fig).
Discussion 
In this study, influenza was significantly associated with 
cardiorespiratory hospitalisation in all age-groups in Hong 
Kong. According to our estimates, influenza accounted for 
29.3 excess P&I hospitalisations per 100 000 inhabitants 
in all age-groups and 11.6% of total hospitalisations. These 
estimates were comparable with those reported by a study 
in the US using a similar Poisson regression approach. 
Annually there was a 36.8 influenza-associated excess 
P&I hospitalisations per 100 000 inhabitants for all ages, 
accounting for 8.6% of all hospitalisations for this diagnosis 
during the period 1979 to 2001.6 Those aged 75+ years had 
the highest hospitalisation rates for all disease categories 
investigated. The influenza-associated hospitalisation for 
ARD was lowest in the 15-39 years age-group, a pattern 
echoed in the US study.6
 Influenza was associated with excess hospitalisation 
for chronic diseases such as CVD and IHD, especially in 
those older than 65 years. Numerous studies have suggested 
that influenza infection may cause damage not only to 
the respiratory system, but also to the circulatory organs. 
Influenza might trigger alterations in circulating clotting 
factors, platelet aggregation and lysis, concentrations 
of inflammatory-response proteins and cytokine 
concentrations. These may enhance thrombotic tendencies, 
impair vasodilation, or even lead to endothelial injury. In 
addition, acute respiratory tract infection is associated with 
an increased risk of myocardial infarction and stroke.7 
 The association between influenza and hospitalisation 
for diabetes was significant. Our study was the first 
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Fig. Excess hospitalisation per 100 000 inhabitants associated 
with influenza at different age-groups 
Age-group (years) Lag (weeks) Excess hospitalisation per year P value
% (95% CI) No. (95% CI) per 100 000 inhabitants
Acute respiratory disease
0-14 0 9.3 (7.7, 10.8) 163.3 (135.2, 189.7) <0.001
15-39 0 7.2 (3.3, 10.8) 6.0 (2.7, 8.9) 0.001
40-64 1 11.0 (7.9, 13.9) 14.9 (10.7, 18.8 ) <0.001
65-74 1 11.5 (8.4, 14.3) 83.8 (61.2, 104.2) <0.001
75+ 0 8.7 (6.5, 10.8) 266.0 (198.7, 330.2) <0.001
All 0 10.9 (9.5, 12.1) 60.6 (52.8, 67.2) <0.001
Pneumonia and influenza
0-14 1 14.7 (11.8, 17.4) 70.4 (56.5, 83.3) <0.001
15-39 1 10.5 (6.1, 14.4) 2.9 (1.7, 4.0) <0.001
40-64 1 8.7 (5.0, 12.1) 6.8 (3.9, 9.4) <0.001
65-74 1 11.0 (8.1, 13.8) 58.7 (43.3, 73.7) <0.001
75+ 0 7.1 (4.8, 9.3) 176.3 (119.2, 231.0) <0.001
All 1 11.6 (10.2, 12.9) 29.3 (25.8, 32.6) <0.001
Table. Influenza-associated excess hospitalisation in Hong Kong from 1996 to 2000, after adjusting for co-variates including 
respiratory syncytial virus
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showing that influenza was associated with hospitalisation 
for diabetes mellitus in persons older than 40 years. 
Although increased morbidity and mortality of diabetes 
during influenza epidemics has long been recognised, 
we were able to assess the excess hospitalisation rates 
due to year-round influenza virus activity rather than in 
epidemic periods alone. The increased hospitalisation 
of diabetic patients may be explained by their impaired 
immune responses, which probably leads to secondary 
bacterial infections and further increases morbidity and 
mortality. Moreover, influenza and its complications may 
increase the chance of diabetic patients suffering a range 
of diabetes-related complications that may or may not be 
directly related to influenza. 
 Young children and the elderly are high-risk groups in 
tropical and subtropical settings; they would most benefit 
from influenza vaccination. Influenza also significantly 
increased the risk of hospitalisation in patients with 
underlying chronic conditions such as CVD, IHD and 
diabetes. These results provide evidence to support the 
promotion of influenza vaccination in patients with these 
chronic diseases.
 Poisson regression modelling is a valid approach 
to assess disease impacts of influenza in tropical and 
subtropical regions with uncertain seasonal patterns of 
virus activity. The estimates based on Poisson regression 
modelling have been proved to be robust to unobserved 
confounding factors such as smoking status and chronic co-
morbidity.8 However, this methodology has the limitation of 
over-controlling underlying seasonal variations of disease 
morbidity in the core model. It is possible that some of this 
seasonal variation may also be attributable to the seasonal 
activity of influenza, but this portion of the variation cannot 
be separated from others in this type of analysis. Therefore, 
our estimates are very likely to underestimate the true 
impact of influenza on hospitalisation. An approach that 
can also capture the seasonal variation of disease morbidity 
associated with influenza virus circulation is needed.
Conclusions
Our study demonstrated an association of influenza with 
hospitalisation, not only for ARD (including P&I), but 
also for chronic diseases such as CVD, IHD, and diabetes 
mellitus. The excess hospitalisation rates associated with 
influenza in Hong Kong were estimated to be close to the 
rates in the US.
 Influenza vaccination in the tropics should be promoted 
to achieve a direct benefit of reducing influenza-associated 
hospitalisation. The Poisson regression approach is 
applicable in estimating disease burden associated with 
influenza in Hong Kong, and can be adapted to other 
subtropical/tropical regions.
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